Thermo Fisher's $3.1B Olink acquisition adds proteomics to its portfolio

The latest stories trending on MedCity News.

Editor's Pick

Top Story Thermo Fisher Adds Proteomics to Its Portfolio Through $3.1B Olink Acquisition Thermo Fisher Scientific is acquiring Olink, a company that provides proteomics analysis tools and services used in drug discovery research. Olink's growing revenue will help shore up a Thermo Fisher business segment whose sales have fallen due to declining Covid-19 testing demand. Sponsored Post US Prescription Drug Costs More Than Double Those in Canada Presented by MedCity News & Buy Canadian Insulin Increasingly, patients in the U.S. look to Canada for more affordable prescription options since the Canadian government regulates drug costs. Some companies have noticed and are beginning to capitalize on the demand. Read More. Should employers also jump on the value-based care bandwagon? If so, why? "Definitely. For employers, value-based care offers a model that aligns with high-quality and the results-driven competitive world in which they conduct day-to-day business. It allows them to measure the tangible benefits of their significant investment in the health and wellness of their employees, and not just tally lost costs for sick care." ~ Chris Turner, Co-Founder & CEO of HealthBook+ Don't miss your opportunity to hear from Chris and other knowledgable speakers at INVEST Digital Health on October 26th at Pegasus Park in Dallas. Register Today

Featured News

Heard at HLTH: Healthcare Execs Share Perspectives on AI, Virtual Health and Value-based Care As part of the Heard at HLTH video series, MedCity News Editor in Chief Arundhati Parmar and Senior Reporter Katie Adams interviewed healthcare executives about innovations in health tech at HLTH 2023 in Las Vegas earlier this month. How Mass General Brigham Is Integrating Behavioral Care Into Its Primary Care Model Mass General Brigham launched a program this month in collaboration with behavioral health medical group Concert Health. Under the program, more than 400 Mass General primary care providers can refer their patients to Concert. The health system's goal is to increase patients' access to diagnoses and treatment for mild to moderate behavioral health issues — particularly for Medicaid patients, who are the most underserved. Obesity Care Startup Launches With $3M in Funding Ilant Health launched out of stealth Tuesday. The company serves employers and payers and helps identify patients in need of obesity treatment and matches them to the care best for them. Can Psychedelic-Assisted Therapy Be Used for Prevention? Psychedelic-assisted therapy is currently used to treat severe mental health conditions. But there is evidence it could help with prevention as well, and more research needs to be done on this, said Sherry Rais, CEO and co-founder of Enthea. Cedars-Sinai's CMIO Has A Piece of Advice for AI Startups At HLTH, Shaun Miller — Cedars-Sinai's chief medical information officer — pointed out one thing he thinks healthcare AI companies haven't quite gotten right yet. He said he would "really like there to be a lot more recognition around the personalization of AI and the ability for technology to understand that not every clinician is the same." Roche Deal Aims to Get Molecular Glues to Stick to Elusive Cancer, Neuro Targets Roche is paying $50 million up front to begin a drug R&D alliance with Monte Rosa Therapeutics, a biotech whose molecular glue technology could address targets previously deemed undruggable. It's Roche's second such deal in the past month.

Resources

Achieve Full HIPAA Compliance With the Help of This Checklist With our free HIPAA checklist, you can effortlessly pinpoint your compliance status and identify any remaining steps needed to achieve full HIPAA compliance. Get started today and easily find out where you stand and what else needs to be done! Download Now

MedCity News • PO Box 901 • New York, NY unsubscribe